COMPARATIVE STUDY OF METHYL PHENYDATE VERSUS ATOMOXETINE IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER.
Not Applicable
- Conditions
- Health Condition 1: null- Attention Deficit Hyperactivity Disorder
- Registration Number
- CTRI/2015/06/005853
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 140
Inclusion Criteria
patients diagnosed with ADHD and between age 6-12 years
Exclusion Criteria
patients below 6 and above 12 years of age and patients with eating or substance use disorder or mental retardation are excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change in ADHD rating scale and CGI scale score before and after treatmentTimepoint: change in ADHD rating scale and CGI scale score before and after treatment
- Secondary Outcome Measures
Name Time Method to avaluate health related quality of life and medication adherence.Timepoint: baseline assessment after 3 months